← Back to Clinical Trials
Recruiting NCT06762184

NCT06762184 Scores in Critically Ill Patients After Craniotomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06762184
Status Recruiting
Phase
Sponsor Beijing Tiantan Hospital
Condition Post-craniotomy
Study Type OBSERVATIONAL
Enrollment 1,600 participants
Start Date 2024-11-01
Primary Completion 2025-03-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,600 participants in total. It began in 2024-11-01 with a primary completion date of 2025-03-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study planned to review patients admitted to three ICU wards at Beijing Tiantan Hospital between 2017 and 2020. It focused on adult patients who had undergone craniotomy and stayed in the ICU for more than 24 hours. Researchers intended to collect patient information, surgery details, complications, and outcomes from medical records. They also planned to gather routine scoring data used at the hospital and double-check its accuracy. Patients would be divided into two groups based on whether they survived or not, and the ability of different scoring systems to predict outcomes would be analyzed. Additionally, the study aimed to group patients by the type of surgery and assess how well the scoring systems predicted outcomes for each group.

Eligibility Criteria

Inclusion Criteria: * Patients admitted to the ICU wards between 2017 and 2020 * Patients underwent craniotomy * Patientshad an ICU stay of more than 24 hours Exclusion Criteria: * Pregnant or lactating women * Patients enrolled in other clinical studies

Contact & Investigator

Central Contact

Jianfang Zhou Zhou, MD

✉ zjfyanger@sina.com

📞 8610-59978451

Frequently Asked Questions

Who can join the NCT06762184 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Post-craniotomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06762184 currently recruiting?

Yes, NCT06762184 is actively recruiting participants. Contact the research team at zjfyanger@sina.com for enrollment information.

Where is the NCT06762184 trial being conducted?

This trial is being conducted at Beijing, Chile.

Who is sponsoring the NCT06762184 clinical trial?

NCT06762184 is sponsored by Beijing Tiantan Hospital. The trial plans to enroll 1,600 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology